Media Diversion in Improving Quality of Life in Patients With Recurrent Gynecologic Cancers Receiving Chemotherapy

Completed · Not applicable

Conditions studied: Female Reproductive Cancer

In brief

This randomized clinical trial studies media diversion in improving quality of life in patients with recurrent gynecologic cancers receiving chemotherapy. Media diversion may improve mood and quality of life in patients having cancer treatment.

Key facts

Study ID

NCT01901835

Run by

University of Wisconsin, Madison

People needed

67

Starts

2014-02-12

Expected to finish

2017-02-08

Last updated by the study team

2019-11-19

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Subjects with pathologically-proven gynecologic malignancies
• Subjects who have previously completed primary treatment for a gynecologic malignancy
• Patients receiving chemotherapy for a recurrent gynecologic cancer at the University of Wisconsin-Madison Carbone Cancer Center (UWCCC)
• Patients must be English speaking
• Patients must have the ability to use audio media and read and understand written English

You may not qualify if…

• Patients unable to use audio or video media due to auditory or ocular dysfunction
• Patients unable to read written English
• Patients who are prisoners or incarcerated

Where it is running

• University of Wisconsin Hospital and Clinics — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.